Literature DB >> 20332821

The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease.

Yan Wang1, Fang Lin, Zheng-Hong Qin.   

Abstract

Post-translational modifications are rapid, effective and reversible ways to regulate protein stability, localization, function, and their interactions with other molecules. Post-translational modifications usually occur as chemical modifications at amino acid residues, including SUMOylation, phosphorylation, palmitoylation, acetylation, etc. These complex biochemical modifications tightly regulate and control a variety of cellular processes. Several forms of post-translational modifications of huntingtin (Htt) have been described. These modifications affect Htt metabolism, protein-protein interactions and cellular toxicity. Cleavage and clearance of mutant Htt, and the interactions between mutant Htt and other cellular proteins are important biochemical events leading to Huntington's disease. Therefore, identifying signaling pathways of Htt modification and evaluating the significance of Htt modifications would lead to a better understanding of the normal function of wild-type Htt and the pathogenic mechanisms of mutant Htt.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332821      PMCID: PMC5560368          DOI: 10.1007/s12264-010-1118-6

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  65 in total

Review 1.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 2.  Autophagy: from phenomenology to molecular understanding in less than a decade.

Authors:  Daniel J Klionsky
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

3.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity.

Authors:  Birgit Schilling; Juliette Gafni; Cameron Torcassi; Xin Cong; Richard H Row; Michelle A LaFevre-Bernt; Michael P Cusack; Tamara Ratovitski; Ricky Hirschhorn; Christopher A Ross; Bradford W Gibson; Lisa M Ellerby
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

5.  Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.

Authors:  H Li; S H Li; Z X Yu; P Shelbourne; X J Li
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

6.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

Review 7.  SUMO on the road to neurodegeneration.

Authors:  Véronique Dorval; Paul E Fraser
Journal:  Biochim Biophys Acta       Date:  2007-03-30

8.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

9.  Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons.

Authors:  Emilie Colin; Diana Zala; Géraldine Liot; Hélène Rangone; Maria Borrell-Pagès; Xiao-Jiang Li; Frédéric Saudou; Sandrine Humbert
Journal:  EMBO J       Date:  2008-07-10       Impact factor: 11.598

10.  HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis.

Authors:  Roshni R Singaraja; Shinji Hadano; Martina Metzler; Scott Givan; Cheryl L Wellington; Simon Warby; Anat Yanai; Claire-Anne Gutekunst; Blair R Leavitt; Hong Yi; Keith Fichter; Lu Gan; Krista McCutcheon; Vikramjit Chopra; Jennifer Michel; Steven M Hersch; Joh-E Ikeda; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

View more
  7 in total

1.  Global Proteome and Ubiquitinome Changes in the Soluble and Insoluble Fractions of Q175 Huntington Mice Brains.

Authors:  Karen A Sap; Arzu Tugce Guler; Karel Bezstarosti; Aleksandra E Bury; Katrin Juenemann; Jeroen A A Demmers; Eric A Reits
Journal:  Mol Cell Proteomics       Date:  2019-05-28       Impact factor: 5.911

2.  Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation.

Authors:  Lauren S Havel; Chuan-En Wang; Brandy Wade; Brenda Huang; Shihua Li; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2011-01-18       Impact factor: 6.150

3.  Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy.

Authors:  Youssef Sari
Journal:  Int J Biomed Sci       Date:  2011-06

4.  Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.

Authors:  Erin E Watkin; Nicolas Arbez; Elaine Waldron-Roby; Robert O'Meally; Tamara Ratovitski; Robert N Cole; Christopher A Ross
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  Glycation potentiates neurodegeneration in models of Huntington's disease.

Authors:  Hugo Vicente Miranda; Marcos António Gomes; Joana Branco-Santos; Carlo Breda; Diana F Lázaro; Luísa Vaqueiro Lopes; Federico Herrera; Flaviano Giorgini; Tiago Fleming Outeiro
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

Review 6.  SUMO-modifying Huntington's disease.

Authors:  Ericks S Soares; Rui D Prediger; Patricia S Brocardo; Helena I Cimarosti
Journal:  IBRO Neurosci Rep       Date:  2022-03-09

7.  Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry.

Authors:  John F Kellie; Richard E Higgs; John W Ryder; Anthony Major; Thomas G Beach; Charles H Adler; Kalpana Merchant; Michael D Knierman
Journal:  Sci Rep       Date:  2014-07-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.